Epicrispr Biotechnologies vs Moderna

Epicrispr Biotechnologies vs Moderna, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Moderna on 77/100.

Epicrispr Biotechnologies logo
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Try Epicrispr Biotechnologies
Moderna logo
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Try Moderna

Where each one leads

Epicrispr Biotechnologies

Leads on none of the measures we hold for both companies.

Moderna

  • our overall score: 77/100 against 62/100
  • agent readiness: 49/100 against 39/100
  • domain rating: 79/100 against 40/100
  • headcount: 6,297 against 51
  • funding raised: $4.5B against $90.0M
  • LinkedIn following: 780,086 against 7,025

At a glance

MeasureEpicrispr BiotechnologiesModerna
What it isEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
CategoryBiotechnology, Therapeutics, Rare Diseases, EpigeneticsBiotechnology, mRNA Technology, Vaccines, Pharmaceuticals
Sells toBusiness modelB2BB2B
OfferingPlatformServices
Founded20202010
HeadquartersSouth San Francisco, United StatesCambridge, United States
StatusActiveActive

Size, funding and growth

MeasureEpicrispr BiotechnologiesModerna
Employees516,297
Open rolesNot published100
Total funding$90.0M$4.5B
Latest roundSeries CFunding Round
LinkedIn followers7,025780,086

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEpicrispr BiotechnologiesModerna
StartupHub scoreOur 0-100 rating62/10077/100
Traction57/10060/100
Team40/10070/100
CommunityNot published13/100
Search visibility20/10046/100
Quality78/10090/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (49/100)
Domain ratingLink authority, 0-10040/10079/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEpicrispr BiotechnologiesModerna
HostingNot detectedAWS
CDNCloudflareCloudFront
CMSWordPressNot detected
FrameworksJquery, Tailwind CSS, BootstrapNext.js
AnalyticsGoogle Analytics 4Not detected

What users say

MeasureEpicrispr BiotechnologiesModerna
Community ratingVisitor votes on StartupHubNot published2.0/5 from 1 vote

Epicrispr Biotechnologies vs Moderna: common questions

Which is better, Epicrispr Biotechnologies or Moderna?

On our 0-100 score Moderna rates higher (77/100 against 62/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.

How do Epicrispr Biotechnologies and Moderna compare on the numbers?

Moderna leads on our overall score (77/100 against 62/100), agent readiness (49/100 against 39/100), domain rating (79/100 against 40/100), headcount (6,297 against 51), funding raised ($4.5B against $90.0M), LinkedIn following (780,086 against 7,025).

Read the full Epicrispr Biotechnologies review and pricing or the Moderna review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.